Psychic disorders during menopause: Depressive disorders and psychoses;Psychische Erkrankungen in der Menopause : Depressive Störungen und Psychosen

Gynakologie

Volumn 14, Issue 1, 2009, Pages 15-19

  Riecher Rossler, Anita ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66949140346     PISSN: 16610199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bergemann N, Riecher-Rässler A: Estrogen effects in psychiatric disorders. Wien, New York; 2005.
2. Riecher-Rössler A, Kuhl H, Bitzer J: Psychische Störungen in Zeiten hormoneller Umstellung bei Frauen - Eine selektive Übersicht. Neuropsychiatrie 2006; 20(3): 155-65.
3. Riecher-Rössler A, de Geyter C: The forthcoming role of treatment with oestrogens in mental health. Swiss Med Wkly 2007; 137: 565-72.
4. Kahn L, Halbreich U: Estrogen's effect on depression. In: Bergemann N, Riecher-Rössler A (ed.): Estrogen effects in psychiatric disorders. Wien, New York; 2005: 145-73.
5. Fink G, et al.: Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996; 16: 325-44.
6. Bitzer J, Riecher-Rössler A: Was sind Frauenleiden? Epidemiologische Aspekte. In: Riecher-Rössler A, Bitzer J (Hrsg.). Frauengesundheit. Ein Leitfaden für die ärztliche und psychotherapeutische Praxis. München; 2005: 13-29.
7. Baumgartner S: Sind geschlechtsspezifische Aspekte in der Diagnostik und Behandlung der schizophrenen Erkrankungen relevant? Neuropsychiatrie 2003; 17(3/4): 134-40.
8. Wiklund I, et al.: Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168: 824-30.
9. Cohen LS, et al.: Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006; 63(4): 385-90.
10. Freeman EW, et al.: Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006; 63(4): 375-82.
11. Zweifel JE, O'Brien WH: A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrin. 1997; 22: 189-212.
12. Riecher-Rössler A: Estrogens and Schizophrenia. In: Bergemann N, Riecher-Rössler A (ed.). Estrogen Effects in Psychiatric Disorders. Wien; 2005: 31-52.
13. Bleuler M: Die spätschizophrenen Krankheitsbilder. Neurology 1943; 15(9): 259-90.
14. Riecher A, et al.: Gender differences in age at onset and course of schizophrenic disorders. In: Häfner H, Gattaz WF (ed.). Search for the causes of schizophrenia. Berlin, Heidelberg; 1991: 14-33.
15. Häfner H, et al.: The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 1998; 33(8): 380-6.
16. Riecher-Rössler A, et al.: What do we really know about lateonset schizophrenia? Eur Arch Psychiatry Clin Neurosci 1997; 247: 195-208.
17. Riecher-Rössler A, Rössler W: The course of schizophrenic psychoses: what do we really know? A selective review from an epidemiological perspective. Eur Arch Psychiatry Clin Neurosci 1998; 248(4): 189-202.
18. Cohen LS, et al.: Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 2003; 160(8): 1519-22.
19. Mall G: Neuere Ergebnisse der Psycho-Endokrinologie. Ärztliche Praxis 1959; XI(40): 1357-60.
20. Mall G: Diagnostik und Therapie ovarieller Psychosen. Zentralblatt für die gesamte Neurologie und Psychiatrie 1960; 155: 250
21. Kulkarni J, et al.: A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 1996; 20: 247-52.
22. Kulkarni J, et al.: Estrogen - a potential treatment for schizophrenia. Schizophr Res 2001; 48: 137-44.
23. Kulkarni J, et al.: Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 2008; 65(8): 955-60.
24. Lindamer LA, et al.: Gender, estrogen, and schizophrenia. Psychoph. Bulletin 1997; 33: 221-8.
25. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 363: 419-27.
26. Rossouw JE, et al. : Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297(13): 1465-77.
27. Birkhäuser MH, et al.: Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008; 11(2): 108-23.
28. Pines A, et al.: IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007; 10(3): 181-94.
29. Harlow BL, et al.: Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2003; 60(1): 29-36.
30. Kuhl H: Psychoendokrinologische Einflussfaktoren. In: Riecher- Rössler A, Bitzer J (Hrsg.). Frauengesundheit. München; 2005: 51-62.
31. Riecher-Rössler A: Östrogene und Psychopharmaka. Östrogene in der Psychiatrie - Psychopharmaka in der Gynäkologie? Ars Medici 2008; 25/26: 1118-21.
32. Toran-Allerand CD, et al.: Autoradiographic localization of [3H]estradiol related to steroid responsiveness in cultures of the newborn mouse hypothalamus and preoptic area. Brain Res 1980; 184(2): 517-22.